Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions (TOS). This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
CSBR'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Champions Oncology Inc'in en son EPS'si $-0.02 olup, $0.09 beklentilerini kazanmamak.
Champions Oncology Inc CSBR'ün son çeyrekteki geliri nasıl performans gösterdi?
Champions Oncology Inc'in son çeyrek geliri $-0.02
Champions Oncology Inc'in gelir tahmini nedir?
3 Wall Street analistine göre, Champions Oncology Inc'in gelir tahmini $17.44M ile $16.28M arasında değişmektedir.
Champions Oncology Inc'in kazanç kalite puanı nedir?
Champions Oncology Inc'in kazanç kalite puanı B+/48.55075'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
Champions Oncology Inc kazançlarını ne zaman rapor eder?
Champions Oncology Inc'in bir sonraki kazanç raporu 2026-06-10'te bekleniyor
Champions Oncology Inc'in beklenen kazançları nelerdir?
Wall Street analistlerine göre Champions Oncology Inc'in beklenen kazançları $16.94M'dir.
Champions Oncology Inc kazanç beklentilerini aştı mı?
Champions Oncology Inc'in son kazançları $16.55M olup, beklentileri kazanmaz.